Regulations establishing a binding administrative dispute resolution (ADR) process for the 340B program were rushed into place last December to defeat lawsuits, are fatally flawed legally and constitutionally, and should be struck down, the main U.S. trade association for drug manufacturers told a federal judge late last month.
PhRMA Urges Court Again to Strike Down 340B Dispute Resolution Process
